Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 6/20 | 0.36 |
| ▸ | PPARD | Q03181 | 6/20 | 0.36 |
| ▸ | PPARA | Q07869 | 6/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29128602 | 0.98 | GPR84 (0.44) | GPR84HSPD1BLMHSPE1PPARG | |
| SCHEMBL8375187 | 0.98 | GPR84 (0.41) | GPR84HSPD1BLMHSPE1AKR1B1 | |
| SCHEMBL28501008 | 0.87 | TDP1 (0.34) | GPR84HSPD1BLMHSPE1ALDH1A1 | |
| SCHEMBL15668855 | 0.85 | HSPD1 (0.39) | GPR84HSPD1BLMHSPE1AKR1B1 | |
| SCHEMBL28500979 | 0.83 | GPR84 (0.41) | GPR84HSPD1BLMHSPE1PPARG | |
| SCHEMBL16736963 | 0.82 | HSPD1 (0.53) | GPR84HSPD1BLMHSPE1PPARD | |
| SCHEMBL342995 | 0.81 | AKR1B1 (0.47) | GPR84HSPD1BLMHSPE1AKR1B1 | |
| SCHEMBL27414215 | 0.81 | GPR84 (0.49) | GPR84HSPD1BLMHSPE1PPARD | |
| SCHEMBL17688065 | 0.80 | GPR84 (0.48) | GPR84HSPD1BLMHSPE1AKR1B1 | |
| SCHEMBL11344354 | 0.80 | GPR84 (0.47) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110891545-B | Pickering emulsion composition comprising pearls in a fatty phase | 莱雅公司 | 2022-07-01 | — | — | CN | claimed |
| EP-3902512-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2021-11-03 | — | — | EP | claimed |
| CN-113015512-A | Anhydrous composition for caring for and/or making up keratin materials | 莱雅公司 | 2021-06-22 | — | — | CN | claimed |
| CN-111971024-A | Solid anhydrous composition for caring for and/or making up keratin materials | 莱雅公司 | 2020-11-20 | — | — | CN | claimed |
| WO-2020133031-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2020-07-02 | — | — | WO | claimed |
| CN-110891545-A | Pickering emulsion composition comprising pearls in a fatty phase | 莱雅公司 | 2020-03-17 | — | — | CN | claimed |
| US-20190226141-A1 | BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES | ORGANOCLICK AB (SE) | 2019-07-25 | — | — | US | claimed |
| EP-3504264-A1 | BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES | OrganoClick AB (SE) | 2019-07-03 | — | — | EP | claimed |
| WO-2018218497-A1 | COMPOSITION OF PICKERING EMULSION COMPRISING PEARLS IN FATTY PHASE | L'OREAL (FR) | 2018-12-06 | — | — | WO | claimed |
| WO-2018038669-A1 | BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES | ORGANOCLICK AB (SE) | 2018-03-01 | — | — | WO | claimed |
| CN-1375273-A | Cosmetic composition comprising special adhesive phase | OREAL (FR) | 2002-10-23 | — | — | CN | claimed |
| EP-0925780-B1 | Non-transfer cosmetic composition comprising a dispersion of polymer particles in a liquid fatty phase | OREAL (FR) | 2002-07-03 | — | — | EP | claimed |
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | L'OREAL, S.A. (FR) | 2002-03-21 | — | — | US | claimed |
| CN-1331967-A | Powder cosmetics and/or make-up and care composition containing specific adhesive | OREAL (FR) | 2002-01-23 | — | — | CN | claimed |
| EP-1044677-B1 | Cosmetic composition containing the combination of a particular ester and a silicone compound | OREAL (FR) | 2001-11-14 | — | — | EP | claimed |
| EP-0930060-B1 | Cosmetic composition without transfer containing a non-filmforming polymer particles dispersion | OREAL (FR) | 2001-06-27 | — | — | EP | claimed |
| EP-0923927-B1 | Long-wearing powderous cosmetic composition comprising a dispersion of polymer particles in a liquid oil phase | OREAL (FR) | 2001-05-30 | — | — | EP | claimed |
| US-5945095-A | Cosmetic composition including a polymeric particle dispersion | L'OREAL (FR) | 1999-08-31 | — | — | US | claimed |
| CN-1225257-A | Non-transfusion cosmetics contg. non-film-forming polymer particles existing in partially non-volatile liquid aoliphatic phase | OREAL (FR) | 1999-08-11 | — | — | CN | claimed |
| EP-0749746-B1 | Cosmetic composition containing a dispersion of polymer particles | OREAL (FR) | 1997-09-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | TTR, GRN, MB | GPR84 4739/4885HSPD1 3257/4885BLM 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.